Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

universal health services inc. - UHS

UHS

Close Chg Chg %
197.52 0.51 0.26%

Closed Market

198.03

+0.51 (0.26%)

Volume: 1.21M

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: universal health services inc. - UHS

UHS Key Data

Open

$195.75

 Day Range

195.08 - 199.12

52 Week Range

133.70 - 243.25

 Market Cap

$13.04B

Shares Outstanding

65.97M

 Public Float

55.53M

Beta

1.30

 Rev. Per Employee

N/A

P/E Ratio

13.14

 EPS

$15.30

Yield

40.48%

 Dividend

$0.20

EX-DIVIDEND DATE

Dec 3, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

876.74K

  

UHS Performance

1 Week
 
 -1.86%
 
1 Month
 
 -2.37%
 
3 Months
 
 -15.10%
 
1 Year
 
 42.69%
 
5 Years
 
 42.08%
 

UHS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About universal health services inc. - UHS

Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.

UHS At a Glance

Universal Health Services, Inc.
Universal Corporate Center
King of Prussia, Pennsylvania 19406-3121
Phone 1-610-768-3300 Revenue 14.28B
Industry Hospital/Nursing Management Net Income 717.49M
Sector Health Services 2023 Sales Growth 6.587%
Fiscal Year-end 12 / 2024 Employees 96,700
View SEC Filings

UHS Valuation

P/E Current 13.144
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 14.899
Price to Sales Ratio 0.748
Price to Book Ratio 1.666
Price to Cash Flow Ratio 8.432
Enterprise Value to EBITDA 9.172
Enterprise Value to Sales 1.12
Total Debt to Enterprise Value 0.336

UHS Efficiency

Revenue/Employee 147,693.65
Income Per Employee 7,419.721
Receivables Turnover 6.381
Total Asset Turnover 1.011

UHS Liquidity

Current Ratio 1.396
Quick Ratio 1.289
Cash Ratio 0.059

UHS Profitability

Gross Margin 8.23
Operating Margin 8.23
Pretax Margin 6.585
Net Margin 5.024
Return on Assets 5.08
Return on Equity 11.889
Return on Total Capital 6.231
Return on Invested Capital 6.418

UHS Capital Structure

Total Debt to Total Equity 87.276
Total Debt to Total Capital 46.603
Total Debt to Total Assets 37.38
Long-Term Debt to Equity 84.052
Long-Term Debt to Total Capital 44.881
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Universal Health Services Inc. - UHS

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
11.56B 12.64B 13.40B 14.28B
Sales Growth
+1.59% +9.37% +5.99% +6.59%
Cost of Goods Sold (COGS) incl D&A
10.20B 11.26B 12.34B 13.11B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
510.49M 533.21M 581.86M 568.04M
Depreciation
478.80M 501.60M 544.00M 535.60M
Amortization of Intangibles
31.69M 31.61M 37.86M 32.44M
COGS Growth
+1.36% +10.42% +9.53% +6.23%
Gross Income
1.36B 1.38B 1.06B 1.18B
Gross Income Growth
+3.31% +1.51% -22.97% +10.77%
Gross Profit Margin
+11.74% +10.90% +7.92% +8.23%
2020 2021 2022 2023 5-year trend
SG&A Expense
- - - -
-
Research & Development
- - - -
-
Other SG&A
- - - -
-
SGA Growth
- - - -
-
Other Operating Expense
- - - -
-
Unusual Expense
(1.36M) 31.22M 57.55M 45.75M
EBIT after Unusual Expense
1.36B 1.35B 1.00B 1.13B
Non Operating Income/Expense
2.82M 32.32M (10.03M) 18.04M
Non-Operating Interest Income
2.80M 1.60M 378.00K 572.00K
Equity in Earnings of Affiliates
1.10M 6.20M 1.20M 874.00K
Interest Expense
109.09M 85.27M 127.27M 207.25M
Interest Expense Growth
-34.52% -21.84% +49.26% +62.84%
Gross Interest Expense
113.35M 89.68M 135.89M 231.67M
Interest Capitalized
4.26M 4.41M 8.62M 24.42M
Pretax Income
1.25B 1.29B 866.26M 940.43M
Pretax Income Growth
+17.42% +3.29% -33.02% +8.56%
Pretax Margin
+10.83% +10.23% +6.46% +6.58%
Income Tax
299.29M 305.68M 209.28M 221.12M
Income Tax - Current - Domestic
312.31M 321.46M 212.09M 232.57M
Income Tax - Current - Foreign
13.98M 13.75M 14.74M 6.50M
Income Tax - Deferred - Domestic
(24.50M) (31.06M) (16.04M) (21.32M)
Income Tax - Deferred - Foreign
(2.50M) 1.52M (1.51M) 3.37M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.10M 6.20M 1.20M 874.00K
Other After Tax Income (Expense)
(2.98M) (2.06M) (748.00K) (308.00K)
Consolidated Net Income
949.81M 985.57M 656.23M 719.00M
Minority Interest Expense
8.84M (3.96M) (18.63M) 1.51M
Net Income
940.97M 989.53M 674.86M 717.49M
Net Income Growth
+15.77% +5.16% -31.80% +6.32%
Net Margin Growth
+8.14% +7.83% +5.04% +5.02%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
940.97M 989.53M 674.86M 717.49M
Preferred Dividends
- - - -
-
Net Income Available to Common
940.97M 989.53M 674.86M 717.49M
EPS (Basic)
11.0974 11.9916 9.2297 10.3502
EPS (Basic) Growth
+21.19% +8.06% -23.03% +12.14%
Basic Shares Outstanding
85.06M 82.52M 73.12M 69.32M
EPS (Diluted)
11.0292 11.8235 9.1405 10.2315
EPS (Diluted) Growth
+20.82% +7.20% -22.69% +11.94%
Diluted Shares Outstanding
85.59M 83.69M 73.83M 70.13M
EBITDA
1.87B 1.91B 1.64B 1.74B
EBITDA Growth
+3.52% +2.31% -14.01% +6.11%
EBITDA Margin
+16.16% +15.11% +12.26% +12.21%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 246.857
Number of Ratings 18 Current Quarters Estimate 4.17
FY Report Date 12 / 2024 Current Year's Estimate 15.929
Last Quarter’s Earnings 3.71 Median PE on CY Estimate N/A
Year Ago Earnings 10.54 Next Fiscal Year Estimate 18.079
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 15 12 16 15
Mean Estimate 4.17 4.21 15.93 18.08
High Estimates 4.51 4.61 16.26 20.09
Low Estimate 3.77 3.91 15.72 16.82
Coefficient of Variance 4.43 5.57 0.87 4.92

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 8 8
OVERWEIGHT 2 2 2
HOLD 9 10 10
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Universal Health Services Inc. - UHS

Date Name Shares Transaction Value
Aug 16, 2024 Alan B. Miller Executive Chairman; Director 1,120,174 Bona fide gift 0.00
Aug 9, 2024 Nina Chen-Langenmayr Director 1,985 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $212.11 per share 421,038.35
May 17, 2024 Warren J. Nimetz Director 3,971 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $180.32 per share 716,050.72
May 17, 2024 Maria Ruderman Singer Director 4,265 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Warren J. Nimetz Director 4,696 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Maria Ruderman Singer Director 3,168 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $179.29 per share 567,990.72
May 17, 2024 Maria Ruderman Singer Director 4,857 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $179.15 per share 870,131.55
May 17, 2024 Maria Ruderman Singer Director 2,500 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Maria Ruderman Singer Director 10,668 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $138.8 per share 1,480,718.40
May 17, 2024 Eileen Claire McDonnell Director 6,413 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Elliot J. Sussman Director 5,048 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2024 Matthew J. Peterson Executive Vice President, UHS 5,217 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2024 Marc Daniel Miller President and CEO; Director 205,273 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2024 Edward H. Sim Executive Vice President 5,415 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2024 Steve G. Filton Executive Vice President & CFO 74,577 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 15, 2024 Alan B. Miller Executive Chairman; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 15, 2024 Marc Daniel Miller President and CEO; Director 182,518 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.78 per share 32,265,532.04
Mar 15, 2024 Alan B. Miller Executive Chairman; Director 65,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 15, 2024 Alan B. Miller Executive Chairman; Director 1,116,208 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $172.63 per share 192,690,987.04
Mar 15, 2024 Alan B. Miller Executive Chairman; Director 1,107,848 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $174.72 per share 193,563,202.56

Universal Health Services Inc. in the News